Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 13 studies | 34% ± 18% | |
| oligodendrocyte | 12 studies | 32% ± 12% | |
| oligodendrocyte precursor cell | 10 studies | 30% ± 15% | |
| GABAergic neuron | 3 studies | 42% ± 7% | |
| glutamatergic neuron | 3 studies | 48% ± 11% | |
| ependymal cell | 3 studies | 35% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 39% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1278.02 | 2642 / 2642 | 100% | 70.42 | 703 / 705 |
| intestine | 100% | 608.48 | 966 / 966 | 94% | 14.95 | 497 / 527 |
| stomach | 100% | 602.89 | 359 / 359 | 92% | 16.12 | 264 / 286 |
| adrenal gland | 100% | 1540.42 | 258 / 258 | 92% | 16.59 | 212 / 230 |
| uterus | 99% | 931.68 | 169 / 170 | 90% | 21.44 | 411 / 459 |
| ovary | 100% | 1283.13 | 180 / 180 | 88% | 17.82 | 379 / 430 |
| lung | 88% | 299.78 | 508 / 578 | 92% | 15.77 | 1067 / 1155 |
| bladder | 100% | 599.86 | 21 / 21 | 73% | 12.53 | 366 / 504 |
| breast | 94% | 466.20 | 432 / 459 | 73% | 10.78 | 817 / 1118 |
| esophagus | 78% | 317.56 | 1133 / 1445 | 85% | 15.34 | 156 / 183 |
| thymus | 99% | 483.31 | 645 / 653 | 62% | 6.32 | 377 / 605 |
| kidney | 80% | 251.33 | 71 / 89 | 73% | 7.35 | 662 / 901 |
| pancreas | 54% | 116.41 | 178 / 328 | 93% | 14.54 | 166 / 178 |
| prostate | 99% | 563.63 | 243 / 245 | 48% | 3.12 | 239 / 502 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.60 | 1 / 1 |
| adipose | 89% | 357.98 | 1068 / 1204 | 0% | 0 | 0 / 0 |
| heart | 88% | 374.54 | 760 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 13.55 | 38 / 45 |
| blood vessel | 84% | 409.93 | 1122 / 1335 | 0% | 0 | 0 / 0 |
| skin | 60% | 342.69 | 1085 / 1809 | 18% | 2.92 | 84 / 472 |
| spleen | 50% | 97.37 | 121 / 241 | 0% | 0 | 0 / 0 |
| liver | 8% | 13.89 | 18 / 226 | 31% | 3.22 | 126 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.64 | 3 / 29 |
| peripheral blood | 7% | 18.07 | 64 / 929 | 0% | 0 | 0 / 0 |
| muscle | 4% | 7.78 | 34 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.14 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006178 | Biological process | guanine salvage |
| GO_0006166 | Biological process | purine ribonucleoside salvage |
| GO_0046038 | Biological process | GMP catabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0000166 | Molecular function | nucleotide binding |
| GO_0004422 | Molecular function | hypoxanthine phosphoribosyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0000287 | Molecular function | magnesium ion binding |
| Gene name | PRTFDC1 |
| Protein name | Phosphoribosyltransferase domain-containing protein 1 |
| Synonyms | HHGP |
| Description | FUNCTION: Has low, barely detectable phosphoribosyltransferase activity (in vitro). Binds GMP, IMP and alpha-D-5-phosphoribosyl 1-pyrophosphate (PRPP). Is not expected to contribute to purine metabolism or GMP salvage. |
| Accessions | ENST00000376378.5 [Q9NRG1-2] ENST00000376376.3 [Q9NRG1-3] ENST00000320152.11 [Q9NRG1-1] Q9NRG1 |
